These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 35896001)

  • 1. Trends in buprenorphine treatment disparities during the COVID pandemic in Massachusetts.
    Wakeman SE; Lambert E; Kung S; Brisbon NM; Carroll AD; Hickman TT; Covahey C; Sequist TD; Weiner SG
    Subst Abus; 2022 Dec; 43(1):1317-1321. PubMed ID: 35896001
    [No Abstract]   [Full Text] [Related]  

  • 2. Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic.
    Nguyen T; Ziedan E; Simon K; Miles J; Crystal S; Samples H; Gupta S
    JAMA Netw Open; 2022 Jun; 5(6):e2214765. PubMed ID: 35648400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Engagement With Opioid Use Disorder Treatment Among Medicaid Beneficiaries During the COVID-19 Pandemic.
    Tilhou AS; Dague L; Saloner B; Beemon D; Burns M
    JAMA Health Forum; 2022 Mar; 3(3):e220093. PubMed ID: 35977284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Disparities in Postpartum Care in the Greater Boston Area During the COVID-19 Pandemic.
    Mi T; Hung P; Li X; McGregor A; He J; Zhou J
    JAMA Netw Open; 2022 Jun; 5(6):e2216355. PubMed ID: 35737390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities in Wait Times for Care Among US Veterans by Race and Ethnicity.
    Gurewich D; Beilstein-Wedel E; Shwartz M; Davila H; Rosen AK
    JAMA Netw Open; 2023 Jan; 6(1):e2252061. PubMed ID: 36689224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.
    Hadland SE; Wharam JF; Schuster MA; Zhang F; Samet JH; Larochelle MR
    JAMA Pediatr; 2017 Aug; 171(8):747-755. PubMed ID: 28628701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access to Medications for Opioid Use Disorder During COVID-19: Retrospective Study of Commercially Insured Patients from 2019-2022.
    Rajagopal S; Westra J; Raji MA; Wilkes D; Kuo YF
    Am J Prev Med; 2024 Apr; 66(4):635-644. PubMed ID: 37979624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of COVID-19 Pandemic-Related Stressors to Racial and Ethnic Disparities in Mental Health During Pregnancy.
    Avalos LA; Nance N; Zhu Y; Croen LA; Young-Wolff KC; Zerbo O; Hedderson MM; Ferrara A; Ames JL; Badon SE
    Front Psychiatry; 2022; 13():837659. PubMed ID: 35360124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
    Currie JM; Schnell MK; Schwandt H; Zhang J
    JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
    Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
    J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic Disparity in Use of Telemedicine for Ambulatory General Surgical Consultation During the COVID-19 Pandemic: Analysis of the Initial Public Health Emergency and Second Phase Periods.
    Eruchalu CN; Bergmark RW; Smink DS; Tavakkoli A; Nguyen LL; Bates DW; Cooper Z; Ortega G
    J Am Coll Surg; 2022 Feb; 234(2):191-202. PubMed ID: 35213441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
    Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
    Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term retention in Office Based Opioid Treatment with buprenorphine.
    Weinstein ZM; Kim HW; Cheng DM; Quinn E; Hui D; Labelle CT; Drainoni ML; Bachman SS; Samet JH
    J Subst Abuse Treat; 2017 Mar; 74():65-70. PubMed ID: 28132702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021.
    Acosta AM; Garg S; Pham H; Whitaker M; Anglin O; O'Halloran A; Milucky J; Patel K; Taylor C; Wortham J; Chai SJ; Kirley PD; Alden NB; Kawasaki B; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Weigel A; Monroe ML; Ryan P; Reeg L; Kohrman A; Lynfield R; Bye E; Torres S; Salazar-Sanchez Y; Muse A; Barney G; Bennett NM; Bushey S; Billing L; Shiltz E; Sutton M; Abdullah N; Talbot HK; Schaffner W; Ortega J; Price A; Fry AM; Hall A; Kim L; Havers FP
    JAMA Netw Open; 2021 Oct; 4(10):e2130479. PubMed ID: 34673962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic.
    Streck JM; Kalkhoran S; Bearnot B; Gupta PS; Kalagher KM; Regan S; Wakeman S; Rigotti NA
    Drug Alcohol Depend; 2021 Jan; 218():108438. PubMed ID: 33271434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural racism and COVID-19 response: higher risk of exposure drives disparate COVID-19 deaths among Black and Hispanic/Latinx residents of Illinois, USA.
    Holden TM; Simon MA; Arnold DT; Halloway V; Gerardin J
    BMC Public Health; 2022 Feb; 22(1):312. PubMed ID: 35168585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial and Ethnic Disparities in Hospitalization Outcomes Among Medicare Beneficiaries During the COVID-19 Pandemic.
    Song Z; Zhang X; Patterson LJ; Barnes CL; Haas DA
    JAMA Health Forum; 2021 Dec; 2(12):e214223. PubMed ID: 35977303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in Outpatient and Telehealth Visits During the COVID-19 Pandemic in a Large Integrated Health Care Organization: Retrospective Cohort Study.
    Qian L; Sy LS; Hong V; Glenn SC; Ryan DS; Morrissette K; Jacobsen SJ; Xu S
    J Med Internet Res; 2021 Sep; 23(9):e29959. PubMed ID: 34351865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and treatment of opioid use disorders among primary care patients in six health systems.
    Lapham G; Boudreau DM; Johnson EA; Bobb JF; Matthews AG; McCormack J; Liu D; Samet JH; Saxon AJ; Campbell CI; Glass JE; Rossom RC; Murphy MT; Binswanger IA; Yarborough BJH; Bradley KA;
    Drug Alcohol Depend; 2020 Feb; 207():107732. PubMed ID: 31835068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
    Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
    Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.